A functional single nucleotide polymorphism -1562c>t in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers

International Journal of Lower Extremity Wounds

Volumn 12, Issue 3, 2013, Pages 199-204

  Singh, Kanhaiya ^a   Agrawal, Neeraj K ^b   Gupta, Sanjeev K ^b   Singh, Kiran ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

diabetic foot ulcer; matrix metalloproteinase; polymorphism

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; DIABETIC FOOT; FEMALE; GELATINASE B GENE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETIC FOOT ULCER; MATRIX METALLOPROTEINASE; POLYMORPHISM;

ALLELES; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES;

EID: 84887571889     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734613493289     Document Type: Article

References (31)

1. Gottlieb MS. Diabetes in offspring and siblings of juvenile- and maturity-onset-type diabetics. J Chronic Dis. 1980 ; 33: 331-339
2. Stern MP, O'Connell P Type 2 Diabetes Prediction and Prevention. Chichester, UK: Wiley ; 1999 :
3. Florez JC, Hirschhorn J, Altshuler D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genom Hum Genet. 2003 ; 4: 257-291
4. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia. 1981 ; 20: 87-93
5. Jeffcoate WJ, Price P, Harding KG. Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev. 2004 ; 20: S78 - S89
6. Whitney JD. Overview: acute and chronic wounds. Nurs Clin North Am. 2005 ; 40: 191-205
7. Van den Steen PE, Proost P, Grillet B, et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002 ; 16: 379-389
8. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999 ; 99: 1788-1794
9. Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998 ; 19: 589-601
10. Wagner FW. The dysvascular foot: a system of diagnosis and treatment. Foot Ankle. 1981 ; 2: 64-122
11. Gremlich S, Nguyen D, Reymondin D, et al. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk. J Reprod Immunol. 2007 ; 74: 143-151
12. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001 ; 414: 813-820
13. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005 ; 54: 1615-1625
14. Barroso I, Luan J, Sandhu MS, et al. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia. 2006 ; 49: 501-505
15. Schwanstecher C, Schwanstecher M. Nucleotide sensitivity of pancreatic ATP-sensitive potassium channels and type 2 diabetes. Diabetes. 2002 ; 51: S358 - S362
16. Cox NJ, Hayes MG, Roe CA, Tsuchiya T, Bell GI. Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes. 2004 ; 53: S19 - S25
17. Silander K, Mohlke KL, Scott LJ, et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes. 2004 ; 53: 1141-1149
18. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006 ; 38: 320-323
19. Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke. 1999 ; 30: 2612-2616
20. Joos L, He JQ, Shepherdson MB, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet. 2002 ; 11: 569-576
21. Kondapaka SB, Fridman R, Reddy KB. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer. 1997 ; 70: 722-726
22. Schafer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008 ; 9: 628-638
23. Chaudhary AK, Pandya S, Mehrotra R, Singh M, Singh M. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C>T and -168 G/T) and MMP-9 (-1562C>T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population. Biomarkers. 2011 ; 16: 577-586
24. Singh K, Nair RR, Khanna A. Functional SNP -1562C/T in the promoter region of MMP9 and recurrent early pregnancy loss. Reprod Biomed Online. 2012 ; 24: 61-65
25. Yager DR, Zhang Y, Liang HX, Diegelmann RF, Cohen IK. Wound fiuids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fiuids. J Invest Dermatol. 1996 ; 107: 743-748
26. Chen C, Schultz GS, Bloch M, Edwards PD, Tebes S, Mast BA. Molecular and mechanistic validation of delayed healing rat wounds as a model for human chronic wounds. Wound Repair Regen. 1999 ; 7: 486-494
27. Liu Y, Min D, Bolton T, et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care. 2009 ; 32: 117-119
28. McLennan SV, Min D, Yue DK. Matrix metalloproteinases and their roles in poor wound healing in diabetes. Wound Pract Res. 2009 ; 16: 116-121
29. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res. 2009 ; 69: 636-645
30. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol. 2004 ; 24: 1479-1484
31. Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003 ; 107: 1579-1585